CompletedPhase 2

Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram

Iraq74 participantsStarted 2021-12-01

Plain-language summary

Worldwide infertility affects about 15 % of reproductive-age couples. In many cases, infertility can't be treated, new treatment options with promising value were involved in the recent clinical trials.

Who can participate

Age range18 Years – 60 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult male patients.
✓. Aged 18 - 60 years.
✓. Confirmed diagnosis with idiopathic Oligo-Astheno-Teratozoospermia (iOAT) syndrome.

Exclusion criteria

✕. Patients who have been found to have additional infertility causes, such as varicocele or Obstruction of the ejaculatory duct.
✕. Those who have had surgery for male factor infertility.
✕. Patients with infections such as STD.
✕. Patient with renal or liver disease
✕. Incomplete patient data

What they're measuring

The seminal fluid analysis

Timeframe: change in value from baseline to the end of 1st, 2nd and 3rd month for three consecutive months of treatment

Trial details

NCT IDNCT05847257

SponsorAl-Mustansiriyah University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10-30

View on ClinicalTrials.gov More Male Reproductive Problem trials